MERCURY, SCIENCE AND POLITICS

January 2008

Dr. Boyd Haley

Professor of Chemistry/Biochemistry

University of Kentucky

VISUALIZATION OF MERCURY EMITTING FROM A DENTAL AMALGAM• From: www.

uninformed concent.com

• David Kennedy’s IAOMT tape

IN SPITE OF THE OBVIOUS EMISSION OF Hg VAPORS FROM DENTAL AMALGAM THE FDA HAS STEADFASTLY REFUSED TO TEST THEM FOR SAFETY!

Mercury from Dental Amalgam1. Pro-amalgam ADA spokespersons “estimate” that

about 0.03 mcg mercury are emitted from a single amalgam per day. Estimate that it would take several hundred amalgams to provide a toxic

exposure.

2. A new IAOMT study shows that different amalgam types emit more mercury and that a

single spill (very small amalgam) emits between 4.0 to 20 mcg of mercury per day at room

temperature and without abrasion of any sort. This is about 133 to 666 times more than was

estimated by the ADA!

IAOMT AMALGAM STUDY PROCEDURE• Nine dentists across the USA volunteered to make 10

cylindrical, one spill amalgams in a provided plexiglass mold.

• The IAOMT provided new amalgam kits directly from the manufacturers to each dentist.

• The amalgams in the molds were sent to Dr. Haley at the University of Kentucky for Hg analysis.

• The amalgams were allowed to age for over one month to eliminate any surface mercury.

• The amalgams were placed in 10 ml of distilled water which was changed daily.

• Aliquots of this water were removed at days indicated and analyzed for mercury content.

DENTISTS BRAND DAY1 DAY4 DAY8 DAY11 DAY15 DAY18 DAY22 DAY25

BASCIANO Valiant 9.921 9.677 9.580 9.463 8.700 8.873 9.392 9.311

    9.751 9.262 8.886 8.202 8.074 8.014 9.563 10.322

    8.075 7.288 7.054 7.288 7.558 7.311 7.315 6.956

ECCLES Dispersalloy 9.966 9.620 10.851 10.590 11.260 9.070 9.280 9.014

    7.322 7.922 9.913 9.279 8.639 6.809 7.542 8.672

    9.206 8.685 8.599 8.480 7.783 8.270 7.936 8.997

FISCHER Valiant 5.958 5.829 4.408 4.533 4.266 4.473 5.136 4.460

    5.280 4.762 4.492 4.279 4.801 4.505 4.300 4.862

    4.596 4.704 4.929 4.867 6.147 5.798 5.936 5.468

GRUBE Valiant 6.841 6.904 6.788 5.782 8.158 7.740 7.893 8.026

    12.458 11.878 11.771 12.404 12.146 10.693 10.484 10.221

    13.911 13.421 12.618 11.176 11.669 13.439 13.208 13.090

MESSERMAN Dispersalloy 11.357 11.238 11.887 12.086 15.335 14.712 14.473 15.859

    17.796 17.484 16.765 19.584 19.321 20.716 20.696 19.995

    15.336 14.602 14.086 18.625 17.759 12.389 16.285 15.580

DENTISTS BRAND DAY1 DAY4 DAY8 DAY11 DAY15 DAY18 DAY22 DAY25

RUBIN Tytin 14.207 13.175 12.244 11.835 11.639 11.568 14.147 13.240

    21.055 20.484 19.769 20.150 22.512 20.912 18.798 16.579

    9.407 8.281 8.693 9.731 9.556 11.781 9.799 9.219

SUKEL Tytin 9.024 8.662 8.272 7.521 8.043 11.216 9.515 8.670

    10.757 10.341 9.713 6.384 7.030 7.540 7.428 6.782

    7.539 7.108 6.656 6.508 6.899 6.508 6.959 8.200

WILLIAMSON Dispersalloy 11.424 10.897 12.077 10.392 10.738 10.976 12.094 11.538

    8.242 7.675 8.123 7.425 7.499 8.872 8.588 8.463

    10.529 10.427 10.553 11.149 10.463 10.156 10.559 10.228

YOO Tytin 9.098 8.063 7.795 7.366 7.994 7.304 9.803 9.305

    10.949 10.216 10.773 10.431 12.250 11.319 12.476 11.197

    15.925 15.525 14.992 12.234 12.797 14.670 14.038 13.647

Literature

• 0.54 µg/g Hg in feces when amalgams are present. This is 540ng/g (see next slide!)

• Daily excretion in feces 60 µg of Hg

Determined and Presented by Dr. David Quig of Doctor’s Data, USA

ELEVATED MERCURY IN IDIOPATHIC DILATED CARDIOMYOPATHY (IDCM).

WHERE DOES THE Hg COME FROM?

LEVELS ng/g Hg SbControls 8.0 1.5IDCM 178,400 19.260Frustaci et al., J. of American College of Cardiology, 33, (6) 1578, 1999. Controls were patients with valvular or ischemic heart disease. ATHLETIC YOUTH DIE OF IDCM. WHY HASN’T NIH REQUESTED PROPOSALS FOR RESEARCH TO STUDY THIS??THIS IS PROOF THAT MERCURY CAN CONCENTRATE IN SPECIFIC TISSUES OR ORGANS OF THE BODY, EVEN IF Hg BLOOD LEVELS ARE FOUND TO BE IN THE NORMAL RANGE.

DeRouen et al. JAMA 295, 1784-92, 2006

?

BOYS

GIRLS

J. Woods, et al., Environmental Health Perspectives (2007) 115;10, 1527-1531.

• The previous slide shows that prolonged exposure to mercury vapor decreases the child’s ability to excrete mercury through their kidneys. Especially affects BOYS.

• This is consistent with the well known toxic effects of mercury on kidneys.

• This explanation is consistent with the reports by the EPA and National Academy of Sciences that 8 to10% of American women have such high Hg body levels that would render increased susceptibility to neurological damage any child they would give birth to.

Activated Matrix Metallo Proteinase (MMP) is involved in numerous inflammatory diseases. Our new research shows MMP is activated by mercury and organic mercury!1. Atrial fibrillation (AF) produces changes in atrial structure and extracellular matrix composition, which is regulated by matrix

metalloproteinases (MMPs) and often occurs in the setting of congestive heart failure.2. Matrix metalloproteinases (MMPs) are thought to participate in the pathogenesis of coronary artery disease (CAD), particularly

in the occurrence of acute coronary syndrome (ACS).3. Matrix metalloproteases (MMPs) are important in many physiological processes including development, reproduction, and

wound repair. Conversely, aberrant MMPs expression can be detrimental, promoting the pathologic destruction of extracellular matrix components in numerous disease states including breast and squamous cell carcinoma.

4. The significance of circulating matrix metalloproteinases -2 and -9 (MMP-2, MMP-9), as well as their tissue inhibitors -1 and -2 (TIMP-1, TIMP-2) in ovarian cancer were studied to assess the possibility of using them in clinical decision-making. Within malignant neoplasias, high circulating TIMP-1 correlated to the aggressive phenotype and unfavorable prognosis.

5. Matrix metalloproteinases (MMPs) are implicated in the pathogenesis of diseases such as Alzheimer's Disease (AD) and amyotrophic lateral sclerosis (ALS). Increased expression of MMP-9 and TIMPs has been reported in postmortem AD and ALS brain tissue, as well as in ALS cerebrospinal fluid (CSF) and plasma.

6. In active MS patients, both with relapsing-remitting and chronic progressive disease MMP-9 mRNA and plasma protein levels were significantly increased compared to healthy controls.

7. Abdominal aortic aneurysms are characterized by degradation of the extracellular matrix, with a reduction in the elastin concentration of the arterial media. These changes are mediated by increased levels of endogenous metalloproteinases (MMPs) within the aorta.

8. These data suggest that the balance of MMP-2 and MMP-9 to TIMP-1 and TIMP-2 expression is an essential factor in the aggressiveness of renal cell carcinoma.

9. Several solid tumors display enhanced expression of matrix metalloproteinases (MMPs), and recently MMP-inhibitors have entered clinical trials. The obtained results support the hypothesis that MMPs and their endogenous inhibitors participate in the invasive process of human osteosarcoma.

NUMEROUS DISEASES INCLUDING SEVERAL CANCERS AND NEUROLOGICAL ILLNESSES ARE ASSOCIATED WITH THE ACTIVATION OF SPECIFIC MATRIX METALLO PROTEINASES (MMP). Hg2+ AND ETHYL-Hg BOTH ACTIVATE A COMMON FORM OF MMP.

BOTH Hg2+ AND THIMEROSAL ACTIVATE MMP-9, AN ENZYME THAT DIGESTS COLLAGEN AND LEADS TO TISSUE BREAKDOWN.

A polyacrylamide gel on which collagen and its peptides have been separated after incubation with MMP-9 with and without preincubation of the enzyme with Hg2+ , PMA or thimerosal.

Results: Digestion of collagen by MMP-9 was greatly enhanced by preincubation with Hg2+, PMA and Thimerosal. Kinetics and concentration effect studies are continuing.

1. Hagele, et al. Mercury Activates Vascular Endothelial Cell Phospholipase-D through Thiols and Oxidative Stress. Inter. J. of Toxicology (2007) 26:57-69. 2.Ionescu, J. G. et al. Increased Levels of Transition Metals in Breast Cancer Tissue. Neuroendocrinology Letters (2006) 27:1, 36-39.

Hg2+ and Thimerosal activate MMP-9. This activation may be inhibited by compounds that chelate Hg2+.

Axonal Transport - A Process Essential for the Survival of Neurons

Dendrite

Microtubule

MembraneBound OrganelleDynienAxon

Kinesin

HgEDTA Induces Aberrant [32P]8N3GTP-ß-Tubulin Interactions Indicative of AD

Alzheimer’s Disease Brain

Normal Brain without and with Hg2+.

EDTA Prevents Cd, Cu & Zn But Not Hg Inhibition of [32P]8N3GTP Photolabeling of Brain ß-Tubulin

SEQUENTIAL AMALGAM EXTRACTION SOLUTIONS INHIBIT THE VIABILITY OF BRAIN

TUBULIN

0

20

40

60

80

100

120

Hours of Amalgam Soak

% Active

Effect of treating neurons in culture with nanomolar levels of Hg2+. Leong et al. University of Calgary

Immunostaining for Tubulin in Neurons treated with Hg2+. Leong et al. University of Calgary.

INHIBITION OF CREATINE KINASE (CK) BY WATER EXPOSED TO AGED AMALGAM . CK IS 97%

INHIBITED IN ALZHEIMER’S DISEASED BRAIN.

0 5 10 15 20 25

0

1

2

4

8

24HR1HR15MIN.CONTROL

ASSAY TIME

MINUTES

RELATIVE LEVEL [32P]-CREATINE PHOSPHATE PRODUCED

Amalgam soak time.

Pink Disease/Acrodynia• Affected 1 in 500 children in late 1800s until about

1940.• Cause was mercurous chloride (calomel) in teething

powers.• Elimination of these mercury containing teething

powders eliminated this disease.• Therefore, it is very plausible that low level

exposure to mercury at an early age could cause a neurological disease.

• Note: Ethylmercury is many times more toxic than mercurous chloride. Lethality is not an absolute measurement of all toxic effects.

Current Situation• Drugs use to treat behavioral disorders (autism, ADHD) has

increased dramatically (369%) in the recent past to where we now spend more on these drugs than we do on antibiotics and asthma drugs for children.

• The USA now spends more on drugs to treat ADHD than it does on antibiotics and asthma drugs.

• 1 of 6 children in the USA have a diagnosed neurodevelopmental problem according to the CDC. About 1 in 166 have autism.

• We have a major problem! • Yet, our FDA, CDC, NIH and AMA ignore the effects of

dental and medical induced exposures to mercury.

Thimerosal Is Composed of Thiosalicylic Acid And Ethyl Mercury, A Known

Neurotoxicant

1. The Merck Index, 12th ed., p. 1590, #9451 (1996).2. Martindale The Extra Pharmacopoeia, 30th ed., 804 (1993).

Water insoluble

Water soluble

Organ Mercury Levels in Infants with Omophaloceles Treated with Thimerosal. Fagan et al. Archives of Disease in Childhood 52, 962-64, 1977

• Between 1969-75, 13 cases were treated, 10 died. Mercury analysis of organs ranged from 65 to 2,700 times normal levels. This appears to be from 9 to 48 topical applications of 0.1% thimerosal applications. NOTE; These children were most likely on antibiotics. Consider the effect on their immune system!

• “Paradoxically, (in another study) 3 infants exposed postnatally (Iraq, Methyl-Hg by ingestion) did not exhibit signs or symptoms, though their blood levels were >1,000ppb, and one was >1,500ppb.” No antibiotics involved! Blood levels are not a measure of toxicity.

• CONCLUSION IN 1977: “Organic mercurial antiseptics should be heavily restricted or withdrawn from hospital use, and the fact that mercury readily penetrates intact membranes and is highly toxic seems to have been forgotten.” Result: Merthiolate (thimerosal) was removed from the market by the FDA due to its inherent toxicity to infants.

RAPID BLOOD TO BRAIN MOVEMENT OF [203Hg]-THIMEROSAL:Gasset et al. Tetratogenicities of Opthalmic Drugs. Arch.

Opthalomology 93, 52-55, 1975.

• Pregnant rabbits were injected subcutaneous with [203Hg]-thimerosal.

• From hour 1 post injection to hour 6 the cpm of 203Hg in the blood decreased from 100,000 to less than 25,000 cpm, or over 75%.

• From hour 2 post injection to hour 6 there was increased cpm of 203Hg in the fetal brain (2 fold), liver (4 fold) and kidney (3 fold).

• Yet the IOM/CDC/AAP states that the rapid loss of mercury from thimerosal from the blood makes it unlikely to be toxic enough to cause autism. Pichichero et al. Lancet 360:1737, 2002

THE BIG MISTAKE!• YET SOME INDIVIDUALS AT THE CDC AND FDA

DECIDED IT WAS OK TO INJECT THIMEROSAL INTO A NEWBORN INFANT AT LEVELS THAT WOULD BE EPA SAFE IF THE INFANT WEIGHED 275 POUNDS!

• The EPA “safe level” was based on mercury exposure from eating fish and whale meat.

• Most of the heavy metal protection in humans is in the intestinal area as we evolved eating and drinking contaminated food and water. This is bypassed on injection of thimerosal or breathing mercury vapor.

• Table 1. US Department of Education statistics on autism in children aged 6-21 served by Individuals

With Disabilities Education Act (IDEA) • • State 1992-1993 2001-2002 % Increase• Alabama 68 904 1,229• Alaska 8 223 2,687• Arizona 199 1,348 577• Arkansas 30 774 2,480• California 1,605 13,257 726• Colorado 14 538 3,743• Connecticut 164 1,470 796• Delaware 15 294 1,860• District of Columbia 0 144 -• Florida 582 4,328 644• Georgia 262 2,462 840• Hawaii 52 380 631• Idaho 39 356 813• Illinois 5 3,802 75,940• Indiana 273 3,262 1,095• Iowa 67 554 727• Kansas 74 743 904• Kentucky 38 1,022 2,589• Louisiana 409 1,297 217• Maine 37 552 1,392• Maryland 28 2,396 8,457• Massachusetts 493 2,681 444• Michigan 288 4,719 1,538• Minnesota 296 3,270 1,005• Mississippi 0 461• Missouri 336 1,953 481

Thimerosal is toxic to tubulin and actin. Combinations of Hg2+ and thimerosal would be at least additive.

Observation

• Thimerosal, or ethyl-mercury, is a potent and rapid inhibitor of many enzymes necessary for human health.

• Thimerosal or ethyl-mercury does not have to break down to Hg2+ to be toxic to these enzymes or structural proteins.

• The inhibition of tubuline polymerization would disrupt neuronal connections and prevent the mitotic spindle formation needed for immune cell division. The latter would induce an immune system suppression.

MOST VACCINES CONTAIN TRACES OF THIMEROSAL EVEN IF IT IS NOT ADDED AS A PRESERVATIVE.

The vaccine thimerosal concentration was (is) 125,000 to 250,000 nanomolar!

Thimerosal in vaccines appeared to be more toxic than pure thimerosal!

Response of Primary Hippocampal Neurons to Thimerosal

Time (hr) After Treatment

0 5 10 15 20 25 30

Neu

ron

Surv

ival

(% I

niti

al N

umbe

r)

0

20

40

60

80

100

120Control10 nM Thimerosal50 nM Thimerosal50 nM Thimerosal1 µM Thimerosal

INCREASED NEURON DEATH

DR. MARK LOVELL’S LAB

Time (hr) After Treatment

0 5 10 15 20 25 30

Neu

ron

Su

rviv

al

(% I

nit

ial

Nu

mb

er)

20

40

60

80

100

120

Control

50 nM thimerosal

50 nM thimerosal+10 nM HgCl2

50 nM thimerosal+ 25 nM HgCl2

10 nM HgCl2

25 nM HgCl2

Hg & THIMEROSAL DISPLAY ADDITIVE TOXICITIES.

RESULT

• The often used argument by pro-thimerosal advocates that the ethylmercury clears the blood to quickly to be toxic displays a lack of complete and intelligent analysis of the data. Don’t accept this argument!

• Early blood mercury loss is most likely a measure of partitioning of Hg into the body and not excretion.

SYNERGISTIC EFFECTS OF HEAVY METALS IS QUITE COMPLEX AND CAN GREATLY ENHANCE

THE TOXICTY OF MERCURY

Shubert et al. Combined Effects in Toxicology--A Rapid systematic Testing Procedure:Cadmium, Mercury & Lead. J. of Toxicology & Environmental Health 4:763, 1978.

1. “the administration of an essentially no response level (LD1) of a mercury salt together with a 1/20 of the LD1 of a lead salt killed all of the animals.” 2. “Generally, a combination was synergistic when the most toxic member was present at or near its LD1 dose in the presence of a much less toxic member.”

2. Conclusion: Mixing borderline toxic levels of two toxic metals (Pb2+ & Hg2+) makes an extremely toxic solution.

Time (hr) After Treatment

0 5 10 15 20 25 30

Neu

ron

Surv

ival

(% In

itial

Num

ber)

0

20

40

60

80

100

120

Control

50 nM thimerosal

500 nM Al(OH)3

1.75 µg Neomycin/ml

50 nM Thimerosal500 nM Al(OH)3

50 nM Thimerosal1.75 µg Neomycin/ml

50 nM Thimerosal500 nM Al(OH)3

1.75 µg Neomycin/ml

Al:NEOMYCIN:TESTOSTERONE EFFECTS

+ TESTOSTERONE

SYNERGISTIC TOXICITIES

50 NANOMOLAR THIMEROSAL

DR. MARK LOVELL

COLLABORATOR

Estradiol Reduces Cumulative Mercury and Associated Disturbances in the Hypothalamus-Pituitary Axis of

Ovariectomized Rats. Oliveria et al. Ecotoxicol. Environ. Safety Jan.10, 2006

• Methyl-mercury induced a decrease in LHRH in the medial hypothalmus and a decrease in plasma levels of LH. These decreases in LHRH and LH were abolished by estrogenic replacement therapy.

• “The estrogenic effects were associated with a reduction of mercury content of the anterior pituitary gland and medial hypothalmus, suggesting a protective estrogenic effect.”

Recent Publication On Thimerosal Exposure and Neurological Disorders: Autism

Effects of Thimerosal on Nerve Growth Factor Signal Transduction and Cell Death in Neuroblastoma Cells. Parran et al., Toxicological Sciences,

2005. Data demonstrated that thimerosal could alter NGF-induced signaling at concentrations lower than those causing neuronal death. Therefore, the neurons growth and properties could be impeded at exceptionally low levels of thimerosal without killing the neurons.

Observations1. The toxicity of Hg2+ and thimerosal are dramatically

enhanced by other heavy metals, antibiotics and testosterone.

2. It appears as if infants are much more susceptible to mercury toxicity than more mature individuals.

3. Female hormone prevents mercury retention and damage in certain areas of the brain. Testosterone enhances thimerosal toxicity.

4. These findings may explain why autism spectrum disorders affect boys at a higher rate than girls.

Mercury Effects on the Immune System• The mitotic spindle is built on tubulin quite similar

to that found in axons of neurons. Therefore, since the cells of the immune system must divide for an effective immune response Hg inhibits this and actively suppresses the immune system.

• Thimerosal is a very potent inhibitor of phagocytosis by mononuclear phagocytes, inhibiting the process at low 1 to 5 nanomolar levels. (Rampersad et al., Transfusion 45(3):384-93,2005). This prevents removal of microbes and ethyl-Hg damaged cells and proteins leading to greater susceptibility for microbe infection and widespread autoimmune problems.

Effects of Antibiotics, Diet and other Metals on Hg Excretion: Found in Published Literature

• Rats exposed to antibiotics were severely impaired in their ability to excrete mercury.

• Rats on milk versus high protein diets were much less able to excrete mercury.

• The great enhancement of synergistic toxicity with Hg and other heavy metals (e.g. lead) is well documented in the literature. We have many children with other heavy metals in their bodies.

• The above confounders have rarely been considered by those who write articles supporting the safety of thimerosal or dental amalgams.

MERCURY BIRTH HAIR LEVELS VS. AMALGAM FILLINGS IN AUTISTIC

AND CONTROL GROUPS

0

2

4

6

8

10

12

14

0-3

Hair Hg level(mcg/g)

Number of amalgams:Control: autistic ratio:

4-5 6-7 8-9 >102.64 6.93 6.70 6.32 17.91

N: 15 22 29 30 43

Autistic

Controls

Data from A. Holmes, M. Blaxill & B. Haley, Int. J. of Toxicology v22, 2003

BIRTH-HAIR MERCURY BY SEVERITY OF AUTISM

0

0.2

0.4

0.6

0.8

1

1.2

1.4

Hair Hg level(ppm)

MildMean=0.71

n=27

Female

Male

ModerateMean=0.46

n=43

SevereMean=0.21

n=24

Data from Amy Holmes, Mark Blaxill & Boyd Haley, Int. J. Tocicology v22, in press, 2003.

Epidemiological Studies• A study on seven-year-old children in the Faeroe Islands

found that blood pressure problems increased with decreased blood Hg. This implies retention toxicity effects of Hg in this comparison.

• In the Sechylles study of >700 children, boys with higher levels of hair mercury performed better on some tests as the Boston Naming test. This implies that ability to excrete increases hair Hg levels, not exposure, in this comparison.

• CONCLUSION: Blood and hair Hg levels are not a measure of exposure at low levels, but rather a measure of both exposure and ability to excrete mercury.

Observation• Mercury from dental amalgams reaches

infants in utero!

• Autistic infants in utero appear to have an impaired ability to excrete mercury when compared to normal children!

• New concept: Low mercury levels in the hair and blood do not imply lack of toxic mercury exposure or retention in the body!

The involvement of the 2004 Institute of Medicine (IOM) report.

• The 2004 IOM committee was funded by the CDC.• The 2004 IOM report cleared thimerosal as being involved

in autism and recommended that no further research be done on this issue but to investigate other more fruitful areas like genetics.

• The 2004 IOM report was based only on 5 epidemiological studies of questionable value.

• The 2004 IOM report totally dismissed the basic science research on thimerosal toxicity and the resultant aberrant biochemistry possibly caused by mercury-like toxicity reported by several research scientists.

• A recent congressionally requested NIH committee looked at the 2004 IOM report and gave it a very bad evaluation.

Who did the Epidemiological Studies the IOM depended on??• The Verstraten studies at first showed autism rates were enhanced by

thimerosal exposure. All the CDC data was lost or destroyed after it was published. Verstraten now works for a major vaccine producer in Europe.

• Two studies were done by Danish (Madsen and Hviid) who worked for the Stantens Serum Institute (SSI). SSI makes thimerosal containing vaccines and sells them to other countries because they are not allowed to be used in Denmark since 1992.

• One study was done in England by E. Miller. After her results were made known to the IOM the National Health Service removed thimerosal from English vaccines.

• Troubling, that the opinion of the FDA is based totally on foreign, conflicted opinions. Why couldn’t the CDC find epidemiologists in the USA to do these studies???

• The Verstraten studies differed from the Danish and English study in that it did not show the dramatic protection effects of thimerosal against autism!!!!! Now also the latest Canadian study from Montreal.

Evidence of Harm

Autism Risks From 5 Sequential Studies by Verstraten et al. of CDC

Study1 Study2 Study3 Study4 Study5 7.62(1999)

2.48

1.691.52(2001) 1.00*

(2005) *i.e., no increased risk of autism compared to low exposure group. Also, no evident protective effect of thimerosal or the value would have been much less than 1.0. Yet the Danish studies showed that removal of thimerosal caused a 20 to 25 fold increase in autism. One of these sets of studies has to be wrong.

After publication in 2005 all of the data for this work was “lost” by the CDC!!!

Go to Safeminds.org to read the FOIA material on the Verstraten studies.

Simpsonwood Meeting

Conflicts with other CDC accepted studies from Europe!

Indicates thimerosal is causal for autism.

1. In USA rate is 1/166 or 60/10,000!

2. Outpatients added in 1995.

3. Large Copenhagen Clinic added in1992.

4. Autism classification changed in 1994.

5. Thimerosal removed from vaccine.

DANISH STUDY

Conclusion; exposure to a potent neurotoxin, thimerosal, prevents autism!!! Nonsense!

Other Considerations• In England, between 1970-1980, about 14.7% of

children were not vaccinated as suggested. Yet a parental autism group there report (Tony Bateson), on the internet, only two cases of autism in non-vaccinated children were found in their search of autistics born during this time frame.

• The UPI series on autism by Dan Olmstead finds:1. Very little, if any, autism in the unvaccinated Amish! 2. Healthfirst, a Chicago Clinic that does not vaccinate in

the first year of birth reports no autistic children born since 1985 from a population of about 35,000 children.

• The dramatic increase in autism in China following the end of the cold war and the importation of Western vaccines (Evidence of Harm by David Kirby).

CRITICAL EXCLUSIONSTHE CDC IGNORING OF THE EARLY REPORT

BY REPORTER DAN OLMSTEAD OF A GREATLY DECREASED RATE OF AUTISM IN

THE NON-VACCINATED AMISH POPULATION IS CRIMINAL!

THERE IS NO RATIONAL EXPLANATION OF THIS EXCEPT TO PUSH FOR RESEARCH IN

OTHER AREAS (GENETICS) TO AVOID FINDING THE POSSIBLE NEGATIVE EFFECTS

OF THE CDC MANDATED VACCINE PROGRAMS. About $25 million has recently been spent to find the “genetic cause of autism” without

success!

THE SMOKING GUN STUDY• Done in Paris, France (since the 2004 IOM committee

recommended NIH not fund thimerosal studies) in a large autism clinic.

• Investigated porphyrin profiles in autistic versus normal children because these profiles are the best indicator for heavy metal toxicity, especially mercury toxicity.

• Found porphyrin profiles that indicated 53% of autistic children surveyed were mercury toxic.

• Reversed toxic porphyrin profiles by treating autistics with a mercury chelator. Therefore, the cause was not genetic, but mercury toxicity.

• Supporting data from Norway has been reported.• Dr. Robert Natal and Dr. Richard Lathe were the lead

researchers in this work published in the International J. Toxicology 2006.

WHAT ARE PORPHYRINS?• Porphyrins are a class of compounds that lead to the

synthesis of heme, the iron binding red compound of hemoglobin that binds oxygen and aids in delivery to cells, where it is used in the mitochondria to help make energy (ATP). Lack of heme or hemoglobin leads to a very pale complexion (ever notice the complexion of autistic children?)

• Heme has other biological uses. It is in the electron transport pathway that makes ATP. A shortage of heme would prevent adequate energy production.

• Heme is needed for active P450 enzymes, the enzymes that modify organic toxins and aid in removing them from the body.

• Heme is needed to remove amyloid protein from human brain to prevent production of amyloid or senile plaques as identified with Alzheimer’s diseased brain.

WHY DMSA/DMPS ARE NOT REAL CHELATORS EVEN THOUGH THEY DO

REMOVE MERCURY.

CH

CHSH

SHC

O

OH

C

O

OH

CH

CHS

SC

O

OH

C

O

OH

HgHg2+x

DMSA

/-S-Hg-S-/ MUST BE LINEAR AND IT CANNOT BE WITH –SH GROUPS ON ADJACENT CARBONS.

WHAT FORMS IS THE EQUIVALENT OF DMSA-S-Hg-S-DMSA OR DMSA-Hg-CYSTEINE TYPE LINKAGES.

DMSA & DMPS WERE DEVELOPED IN THE 1940s!

O O

NH NH

SH SH

NO O

NH NH

SH SH

Antioxidant Chelating Agents

Benzene bis-amido bis-thiol Pyridine bis-amido bis-thiol

R-S-Hg-S-R linear

Water insoluble, but lipid soluble, coupling with glutathione makes this compound water soluble.

OHO

NH2O

NH

O NH

O

OH

S

OO

NH NH

S S

OOO O

CH3 CH3 OH O

NH2O

NH

ONH

O

OH

S

Glutathione derivative of Functionalized Mercury Chelating Agents

Glutathione Glutathione

Note: Molecule would be charged and water soluble at pH 7.4.

Very water soluble

Antioxidant Properties•When Hg2+ is bound to CT-01 it takes treatment with

239oC to effect its release.

•Treatment of the CT-01-Hg complex with aqueous solutions of pH 2.0 to 12.0 did not cause release of

Hg2+.

•CT-01, when added to aqueous Hg2+ solutions forms a precipitate that is water insoluble but soluble in

certain organic solutions.

•I think it is unlikely that Hg2+ bound to CT-01 would ever be released in the human body.

OH

O

SH

SH

O

OH

SH SO3H

SH

Na.

DMPS DMSA

Both contain acidic groups that are charged at physiological pHs.

New Antioxidant Partitioning Concept• Most available antioxidants are water soluble because they

carry ionic charges. DMPS, DMSA, glutathione, and Se2- are all charged. Therefore, they are not efficient at removing Hg2+ or hydroxyl radicals that are located in fatty (hydrophobic) environments or inside of cells.

• Most toxin generated reactive oxygen species (ROSs) in the body are not available to DMPS, etc. for binding as they are intracellular or in hydrophobic locations.

• The new antioxidants release a very effective antioxidant chelator that enters hydrophobic areas. Entering the hydrophobic regions increases the time in the body enhancing the treatment capability.

Toxicity Study of Lipid Soluble Antioxidant• GroupA B C D• Test 10 100 200 300• Test 20 200 300 400• Test 30 300 400 500• Total 0 600 900 1,200

• Test 40 - 1,500 1,500

• Procedure: Rats were injected under the skin in the stomach area with compound to the amount in μMoles/kg body weight. Three days pause was between each treatment.

• Result: No toxicity or weight loss was observed.

Protection Against Mercury Induced Oxidative Stress• Rats given a lethal dose of Hg2+ died within 3 days

exhibiting head tremors and convulsions before death.• Rats similarly injected with Hg2+ but 20 minutes later given

the new chelator did not show any signs of toxicity except to drink more water and appear slightly less energetic for two days. They fully recovered and were quite active after 5 months. No signs of tumors, etc.

• A FDA certified toxicology laboratory has confirmed that the new chelator is not toxic at 5grams/kg body weight, the highest testing level! Nor did mice given 1.0g/kg body weight for 28 straight days demonstrate any toxic effects.

• This research is being done for the purpose of obtaining FDA approval for these new antioxidants.

Conclusions1. Mercury is released from dental amalgams at levels that greatly exceed the

“estimated” values of amalgam defenders.2. Mercury collects in heart tissue of IDCM subjects at incredibly high levels—yet

this is ignored by the medical and dental community.3. After 2 years exposure children, especially boys, lose the ability to excrete

mercury via urine. This is due to the retention toxic properties of Hg.4. Hg2+ is exceptionally neurotoxic and inhibits the properties of enzymes known to

be inhibited in Alzheimer’s diseased brain when added directly to human brain homogenates or in rats exposed to mercury vapor.

5. Water in which amalgams have been soaked inhibit the same enzymes known to be inactive in Alzheimer’s diseased brain.

6. The relative risk of APO-E genotypes can be explained by the ability of the various APO-E forms to bind mercury in the CSF.

7. Mercury reacts with the known toxins of anaerobic infections to produce very toxic organic mercury compounds. Periodontal disease is highly correlated with numerous systemic illnesses.

8. MMP, an enzyme whose activation is associated with numerous disease progressions, is activated by mercury. So is phospholipase-D.

9. Mercury products, like dental amalgam, due to their release of toxic mercury and proven exacerbation of disease effects have no place in modern dentistry or medicine.